Literature DB >> 16154356

Salient molecular features of hepatitis C virus revealed.

Christoph Seeger1.   

Abstract

Hepatitis C virus (HCV) is a positive strand RNA virus with a narrow host and tissue tropism. It ranks among the most significant of human pathogens, causing inflammation, scarring and cancer of the liver. Recent investigations have shed light on some of the salient molecular features of this virus. These include a requirement for CD81 (a tetraspanin transmembrane protein for viral entry), a novel mechanism for the initiation of RNA synthesis, phosphorylation of a viral protein in the regulation of RNA amplification and virus assembly and, finally, a viral protease suppressing activation of the innate immune response in infected cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16154356     DOI: 10.1016/j.tim.2005.08.011

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  4 in total

1.  Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver.

Authors:  Stefan Wieland; Zuzanna Makowska; Benedetta Campana; Diego Calabrese; Michael T Dill; Josan Chung; Francis V Chisari; Markus H Heim
Journal:  Hepatology       Date:  2014-04-25       Impact factor: 17.425

2.  Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus.

Authors:  Dong Jiang; Haitao Guo; Chunxiao Xu; Jinhong Chang; Baohua Gu; Lijuan Wang; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

Review 3.  Hepatitis C virus proteins.

Authors:  Jean Dubuisson
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

Review 4.  Strategies for targeting tetraspanin proteins: potential therapeutic applications in microbial infections.

Authors:  Noha Hassuna; Peter N Monk; Gregory W Moseley; Lynda J Partridge
Journal:  BioDrugs       Date:  2009       Impact factor: 5.807

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.